NAVB NAVB

Navidea Biopharmaceuticals Stock Price

0.5056
-0.0118 (-2.28%)
0.5056
Volume 132,806
Bid Price
Ask Price
News -
Day High 0.52

Low
0.50

52 Week Range

High
1.83

Day Low 0.50
Company Name Stock Ticker Symbol Market Type
Navidea Biopharmaceuticals Inc NAVB AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0118 -2.28% 0.5056 16:27:51
Open Price Low Price High Price Close Price Prev Close
0.52 0.50 0.52 0.5056 0.5174
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
324 132,806 $ 0.508456 $ 67,526 - 0.50 - 1.83
Last Trade Time Type Quantity Stock Price Currency
16:10:00 542 $ 0.5056 USD

Period:

Draw Mode:

Navidea Biopharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 15.35M 30.36M 22.12M $ 531.51k $ - -0.40 -1.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -15.00k 41.60%

more financials information »

Navidea Biopharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NAVB Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.570.5798990.500.5283604109,549-0.0644-11.3%
1 Month0.700.73140.500.568608580,538-0.1944-27.77%
3 Months0.811.050.500.647007647,968-0.3044-37.58%
6 Months0.871.240.500.9457305205,488-0.3644-41.89%
1 Year1.721.830.501.03137,685-1.21-70.6%
3 Years0.50895.35690.502.07353,428-0.0033-0.65%
5 Years0.4055.35690.10011.31376,6860.100624.84%

Navidea Biopharmaceuticals Description

Navidea Biopharmaceuticals Inc is a biotechnology company specialized in precision medicine. Its products, precision immunodiagnostic agents and immunotherapeutic products are designed to assist in the identification of undetected diseases and to improve targeted treatment. The company's platform, known as Manocept technology, aims to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. One of the company's products is Lymphoseek, a radioactive diagnostic agent indicated to locate lymph nodes.


Your Recent History
AMEX
NAVB
Navidea Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now